Antibodies against the main immunogenic region of the acetylcholine receptor correlate with disease severity in myasthenia gravis; Multicenter Study
Project/Area Number |
25461284
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Neurology
|
Research Institution | Nagasaki Kawatana Medical Center |
Principal Investigator |
Narita Tomoko 独立行政法人国立病院機構長崎川棚医療センター(臨床研究部), その他部局等, 研究員 (20549373)
|
Co-Investigator(Kenkyū-buntansha) |
Motomura Masakatsu 長崎総合科学大学, 工学(系)研究科(研究院), 教授 (70244093)
Nakane Shunya 熊本大学, 医学部附属病院, 寄付講座教員 (70398022)
|
Co-Investigator(Renkei-kenkyūsha) |
Matsuo Hidenori 独立行政法人国立病院機構長崎川棚医療センター(臨床研究部), 医学系, 教授 (20380975)
Suzuki Shigeaki 慶応義塾大学, 大学病院, 講師 (50276242)
Murai Hiroyuki 九州大学, 大学病院, 准教授 (80325464)
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2015: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2014: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2013: ¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
|
Keywords | 重症筋無力症 / 主要免疫原性領域 / MIR / アセチルコリン受容体 / AChR抗体 / MIR抗体 / 抗アセチルコリン受容体抗体 |
Outline of Final Research Achievements |
MG is a disease caused by autoimmune reaction at neuromuscular junction mediated antibodies.Antibody that binds to the acetylcholine receptor (AChR Ab) is useful diagnostically because it detected in more than 80% of MG patients. On the other hand, there is less correlation between AChR Ab titer and clinical symptoms and severity.In this study, we have succeeded in the measurement of antibody against main immunogenic regions (MIR antibody) to competitive inhibition of the monoclonal antibody and the patient serum against epitopes that are cause mainly immune response.
|
Report
(4 results)
Research Products
(2 results)